268 related articles for article (PubMed ID: 27581786)
1. Drug-resistant CXCR4-positive cells have the molecular characteristics of EMT in NSCLC.
Yin H; Wang Y; Chen W; Zhong S; Liu Z; Zhao J
Gene; 2016 Dec; 594(1):23-29. PubMed ID: 27581786
[TBL] [Abstract][Full Text] [Related]
2. MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.
Kitamura K; Seike M; Okano T; Matsuda K; Miyanaga A; Mizutani H; Noro R; Minegishi Y; Kubota K; Gemma A
Mol Cancer Ther; 2014 Feb; 13(2):444-53. PubMed ID: 24258346
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway.
Zheng CH; Chen XM; Zhang FB; Zhao C; Tu SS
Cell Biol Int; 2018 Sep; 42(10):1386-1394. PubMed ID: 29972256
[TBL] [Abstract][Full Text] [Related]
4. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
[TBL] [Abstract][Full Text] [Related]
5. Implication of epithelial-mesenchymal transition in IGF1R-induced resistance to EGFR-TKIs in advanced non-small cell lung cancer.
Zhou J; Wang J; Zeng Y; Zhang X; Hu Q; Zheng J; Chen B; Xie B; Zhang WM
Oncotarget; 2015 Dec; 6(42):44332-45. PubMed ID: 26554308
[TBL] [Abstract][Full Text] [Related]
6. Gefitinib promotes CXCR4-dependent epithelial to mesenchymal transition via TGF-β1 signaling pathway in lung cancer cells harboring EGFR mutation.
Zhu Q; Zhang Z; Lu C; Xu F; Mao W; Zhang K; Shou H; Liu Z; Gu J; Ge D
Clin Transl Oncol; 2020 Aug; 22(8):1355-1363. PubMed ID: 31900845
[TBL] [Abstract][Full Text] [Related]
7. PLEK2 mediates metastasis and vascular invasion via the ubiquitin-dependent degradation of SHIP2 in non-small cell lung cancer.
Wu DM; Deng SH; Zhou J; Han R; Liu T; Zhang T; Li J; Chen JP; Xu Y
Int J Cancer; 2020 May; 146(9):2563-2575. PubMed ID: 31498891
[TBL] [Abstract][Full Text] [Related]
8. CXCR4 is involved in CD133-induced EMT in non-small cell lung cancer.
Tu Z; Xie S; Xiong M; Liu Y; Yang X; Tembo KM; Huang J; Hu W; Huang X; Pan S; Liu P; Altaf E; Kang G; Xiong J; Zhang Q
Int J Oncol; 2017 Feb; 50(2):505-514. PubMed ID: 28000861
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.
Jung MJ; Rho JK; Kim YM; Jung JE; Jin YB; Ko YG; Lee JS; Lee SJ; Lee JC; Park MJ
Oncogene; 2013 Jan; 32(2):209-21. PubMed ID: 22370645
[TBL] [Abstract][Full Text] [Related]
10. Effects of FOXJ2 on TGF-β1-induced epithelial-mesenchymal transition through Notch signaling pathway in non-small lung cancer.
Yang Q; Cao X; Tao G; Zhou F; Zhao P; Shen Y; Chen X
Cell Biol Int; 2017 Jan; 41(1):79-83. PubMed ID: 27611107
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
12. Pirfenidone plays a biphasic role in inhibition of epithelial-mesenchymal transition in non-small cell lung cancer.
Fujiwara A; Shintani Y; Funaki S; Kawamura T; Kimura T; Minami M; Okumura M
Lung Cancer; 2017 Apr; 106():8-16. PubMed ID: 28285699
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of SATB2 is critical for induction of epithelial-to-mesenchymal transition and invasion of NSCLC cells.
Kucuksayan H; Ozes ON; Akca H
Lung Cancer; 2016 Aug; 98():122-129. PubMed ID: 27393518
[TBL] [Abstract][Full Text] [Related]
14. CD44 silencing decreases the expression of stem cell-related factors induced by transforming growth factor β1 and tumor necrosis factor α in lung cancer: Preliminary findings.
Nurwidya F; Takahashi F; Kato M; Baskoro H; Hidayat M; Wirawan A; Takahashi K
Bosn J Basic Med Sci; 2017 Aug; 17(3):228-234. PubMed ID: 28446126
[TBL] [Abstract][Full Text] [Related]
15. miR-16 mimics inhibit TGF-β1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells.
Wang H; Zhang Y; Wu Q; Wang YB; Wang W
Oncol Rep; 2018 Jan; 39(1):247-254. PubMed ID: 29138833
[TBL] [Abstract][Full Text] [Related]
16. Interaction between non-small-cell lung cancer cells and fibroblasts via enhancement of TGF-β signaling by IL-6.
Abulaiti A; Shintani Y; Funaki S; Nakagiri T; Inoue M; Sawabata N; Minami M; Okumura M
Lung Cancer; 2013 Nov; 82(2):204-13. PubMed ID: 24011634
[TBL] [Abstract][Full Text] [Related]
17. RCCD1 depletion attenuates TGF-β-induced EMT and cell migration by stabilizing cytoskeletal microtubules in NSCLC cells.
Wu J; He Z; Yang XM; Li KL; Wang DL; Sun FL
Cancer Lett; 2017 Aug; 400():18-29. PubMed ID: 28455245
[TBL] [Abstract][Full Text] [Related]
18. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
19. Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis.
Zhang N; Liu Y; Wang Y; Zhao M; Tu L; Luo F
Drug Des Devel Ther; 2017; 11():969-983. PubMed ID: 28405157
[TBL] [Abstract][Full Text] [Related]
20. miR‑181b‑5p mediates TGF‑β1-induced epithelial-to-mesenchymal transition in non-small cell lung cancer stem-like cells derived from lung adenocarcinoma A549 cells.
Li X; Han J; Zhu H; Peng L; Chen Z
Int J Oncol; 2017 Jul; 51(1):158-168. PubMed ID: 28534939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]